---
title: "Galeas At Home Bladder Cancer Genome Testing"
ocid: "ocds-h6vhtk-06468a"
canonical_url: "https://d3tenders.com/contract/?ocid=ocds-h6vhtk-06468a"
markdown_url: "https://d3tenders.com/contract/ocds-h6vhtk-06468a.md"
json_url: "https://d3tenders.com/contract/ocds-h6vhtk-06468a.json"
source: "Find A Tender Service"
current_stage: "Award"
buyer: "NHS WALES SHARED SERVICES PARTNERSHIP-PROCUREMENT SERVICES (HOSTED BY VELINDRE UNIVERSITY NHS TRUST)"
published: "2026-03-11"
---

# Galeas At Home Bladder Cancer Genome Testing

Buyer: NHS WALES SHARED SERVICES PARTNERSHIP-PROCUREMENT SERVICES (HOSTED BY VELINDRE UNIVERSITY NHS TRUST)  
Current stage: Award  
OCID: ocds-h6vhtk-06468a

[View canonical contract page](https://d3tenders.com/contract/?ocid=ocds-h6vhtk-06468a)  
[Download OCDS JSON](https://d3tenders.com/contract/ocds-h6vhtk-06468a.json)

## Summary

The NHS Wales Shared Services Partnership-Procurement Services, hosted by Velindre University NHS Trust, has awarded a contract to Informed Genomics Ltd for the delivery of Galeas At Home Bladder Cancer Genome Testing under the direct procurement method. The initiative involves up to 750 at-home bladder cancer genome tests, reporting results to a cloud-based platform, with the process supported by Hywel Dda, Aneurin Bevan, and Swansea Bay University Health Boards. The contract, valued at GBP 252,000, commenced on 9 March 2026 and will run until 8 September 2026. This procurement falls within the medical equipment category, addressing healthcare needs in various regions across Wales, and aims to enhance bladder cancer diagnosis through an innovative home-based method. The contract is awarded based on technical reasons due to Informed Genomics Ltd's unique offering of non-invasive home testing solutions.

This tender presents significant growth opportunities for businesses engaged in medical equipment and diagnostics. SMEs specialising in next-generation sequencing and cloud-based reporting platforms can leverage the demand for non-invasive diagnostic tools. The streamlined procurement process via direct award and the focus on innovative medical solutions highlight an effective entry point for research-focused enterprises and suppliers with expertise in genome testing and digital health solutions. This contract underscores the potential for businesses to develop partnerships with health boards and contribute to advancements in patient care pathways, notably in cancer diagnostics and treatment efficiency.

## Notice

Hywel Dda University Health Board (HDUHB), Aneurin Bevan University Health Board (ABUHB), and Swansea Bay University Health Board (SBUHB) have awarded a contract to Informed Genomics Ltd for the delivery of up to 750 at home bladder cancer genome tests (Galeas) as well as the reporting of results to a cloud-based platform. Cancer Research UK's data shows that bladder cancer is the 9th most common cause of cancer death in the UK, accounting for 3% of all new cancer cases in the UK, with around 2,800 new cases in females and 7,600 new cases for males every year (2017-2019). The NHS Wales National Optimal Pathway (NOP) for bladder cancer has been developed as part of the Single Cancer Pathway (SCP), which aims to establish consistent generic and site-specific pathways that describe all routes of entry onto the pathway from the point of suspicion (PoS) of cancer. Following PoS, a GP referral is made, or referrals are made as a result of incidental findings, ward referrals, or emergency presentation. Where blood is visible and non-visible in urine, patients are referred for testing, necessitating a diagnostic procedure as the first episode of care, typically a flexible cystoscopy procedure. Most diagnostic referrals are to rule out bladder cancer suspicion in patients, with an invasive flexible cystoscopy procedure being undertaken. Following the diagnostic pathway, where bladder cancer is confirmed, the patient will enter the treatment pathway. The Urology Clinical Implementation Network (CIN) has identified a provider in the marketplace, Informed Genomics Ltd., who offer an innovative genome testing kit (Galeas) that can identify bladder cancer through urine samples collected at home. GALEAS Bladder is a simple urine test for bladder cancer that delivers results equivalent to a cystoscopy. A completely non-invasive test, GALEAS Bladder is a sample-to-report urine test developed in partnership with University of Birmingham which uses next generation sequencing to interrogate somatic mutations found across all grades and stages, which detects bladder cancer. A sensitive diagnostic test, the GALEAS Bladder is equivalent to cystoscopy for all grades and stages of bladder cancer, including non-muscle invasive bladder cancer (NMIBC) and muscle invasive bladder cancer (MIBC). Results are reported into a cloud based GALEAS software, providing clinicians with results digitally. This innovative test offers many benefits, including patient experience, where urine samples can be collected at home in a non-invasive manner, reducing the need to travel for invasive procedures. Patient outcomes will also be improved due to the reduced turnaround time for results (provided within one (1) week of receipt of sample). This timely receipt of diagnostic results will allow clinicians to make informed decisions on patient care and pathways, with treatment provided in a timely manner, reducing the risk of cancer progressing to further stages. Current figures suggest this will reduce current pathway by seven (7) weeks. HDUHB, ABUHB, and SBUHB will trial up to 750 tests to be called off over six (6) months. Volumes per Health Board are as follows: HDUHB 300 tests, ABUHB 200 tests, SBUHB 250 tests.

### Procurement Information

Single suppliers technical reasons

## Key Details

| Field | Value |
| --- | --- |
| Publication source | Find A Tender Service |
| Latest notice | https://www.find-tender.service.gov.uk/Notice/022076-2026 |
| Notice type | UK7 - Contract Details Notice |
| Procurement type | Standard |
| Procurement category | Goods |
| Procurement method | Direct |
| Procurement method details | Direct award |
| Tender suitability | SME |
| Awardee scale | SME |
| All stages | Award |

## Dates

| Field | Value |
| --- | --- |
| Publication date | 11 Mar 2026 |
| Submission deadline | Not specified |
| Future notice date | Not specified |
| Award date | 4 Feb 2026 |
| Contract period | 9 Mar 2026 - 8 Sep 2026 |
| Recurrence | Not specified |

## Values

| Field | Value |
| --- | --- |
| Tender value | Not specified |
| Lots value | Not specified |
| Awards value | £210,000 |
| Contracts value | £210,000 |

## Status

| Field | Value |
| --- | --- |
| Tender status | Complete |
| Lots status | Complete |
| Awards status | Active |
| Contracts status | Active |

## Buyer

| Field | Value |
| --- | --- |
| Main buyer | NHS WALES SHARED SERVICES PARTNERSHIP-PROCUREMENT SERVICES (HOSTED BY VELINDRE UNIVERSITY NHS TRUST) |
| Locality | CARDIFF |
| Post town | Cardiff |
| Postcode | CF14 3UZ |
| Country | Wales |
| ITL 1 | TLL Wales |
| ITL 2 | TLL5 South East Wales |
| ITL 3 | TLL52 Cardiff and Vale of Glamorgan |
| Local authority | Cardiff |
| Electoral ward | Gabalfa |
| Westminster constituency | Cardiff North |
| Delivery location | Not specified |

## Supplier

| Field | Value |
| --- | --- |
| Number of suppliers | 1 |
| Supplier names | INFORMED GENOMICS |

## CPV Codes

### Divisions

- 33 - Medical equipments, pharmaceuticals and personal care products

### Codes

- 33100000 - Medical equipments

## Release History

- 11 Mar 2026 at 19:25 - Award - UK7 - Contract Details Notice - https://www.find-tender.service.gov.uk/Notice/022076-2026
- 4 Feb 2026 at 10:21 - Award - UK5 - Transparency Notice - https://www.find-tender.service.gov.uk/Notice/009819-2026

## Documents

- https://www.find-tender.service.gov.uk/Notice/022076-2026
  11th March 2026 - Contract details notice on Find a Tender
- https://www.find-tender.service.gov.uk/Notice/009819-2026
  4th February 2026 - Transparency notice on Find a Tender

## Notice URLs

- http://nwssp.nhs.wales/ourservices/procurement-services/
- https://www.legislation.gov.uk/ukpga/2023/54/contents

## Provenance

This Markdown file is an alternate public rendering of the D3 Tenders contract record. The canonical page is https://d3tenders.com/contract/?ocid=ocds-h6vhtk-06468a. The underlying structured data is available as OCDS JSON at https://d3tenders.com/contract/ocds-h6vhtk-06468a.json.